Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 2/20 | 0.51 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.51 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.50 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.47 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.47 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.47 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.47 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.47 |
| ▸ | P2RY1 | P47900 | 5/20 | 0.47 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL502621 | 0.99 | ENPP1 (0.52) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL8509835 | 0.99 | ENPP1 (0.50) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL27721221 | 0.89 | FGFR1 (0.47) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL283730 | 0.88 | FGFR1 (0.51) | ENPP1ENPP3P2RY2FGFR1SLC22A6 | |
| Acetone SCHEMBL28162073 | 0.83 | CYP3A4 (0.47) | ENPP1P2RY2FGFR1SLC22A6P2RY1 | |
| Niacinamide SCHEMBL27733580 | 0.83 | EGFR (0.52) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL27903676 | 0.83 | CYP3A4 (0.47) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL5089696 | 0.82 | ENPP1 (0.46) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL1074484 | 0.81 | CDK1 (0.40) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL28139965 | 0.81 | FGFR1 (0.43) | ENPP1ENPP3P2RY2P2RX1P2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11129930-B2 | System and method for obtaining a cellular sample enriched with defined cells such as platelet rich plasma (PRP) | ESTAR TECHNOLOGIES LTD (IL) | 2021-09-28 | — | — | US | claimed |
| EP-1877757-B1 | METHOD FOR USING AN ALL SOLID-STATE FLUOROMETER IN MONITORING AND CONTROLLING CHEMICALS IN WATER | NALCO CO (US) | 2021-03-10 | — | — | EP | claimed |
| US-20200215254-A1 | SYSTEM AND METHOD FOR OBTAINING A CELLULAR SAMPLE ENRICHED WITH DEFINED CELLS SUCH AS PLATELET RICH PLASMA (PRP) | ESTAR TECHNOLOGIES LTD (IL) | 2020-07-09 | — | — | US | claimed |
| CN-103717753-B | System and method for genetic and biological analysis | 吉纳普赛斯股份有限公司 | 2016-12-07 | — | — | CN | claimed |
| US-20140329699-A1 | SYSTEMS AND METHODS FOR HIGH EFFICIENCY ELECTRONIC SEQUENCING AND DETECTION | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2014-11-06 | — | — | US | claimed |
| CN-104105797-A | System and method for efficient electronic sequencing and detection | GENAPSYS INC | 2014-10-15 | — | — | CN | claimed |
| EP-2785868-A1 | SYSTEMS AND METHODS FOR HIGH EFFICIENCY ELECTRONIC SEQUENCING AND DETECTION | Genapsys Inc. (US) | 2014-10-08 | — | — | EP | claimed |
| CN-103717753-A | System and method for genetic and biological analysis | GENAPSYS INC | 2014-04-09 | — | — | CN | claimed |
| WO-2013082619-A1 | SYSTEMS AND METHODS FOR HIGH EFFICIENCY ELECTRONIC SEQUENCING AND DETECTION | GENAPSYS, INC. (US) | 2013-06-06 | — | — | WO | claimed |
| WO-2012166742-A2 | SYSTEMS AND METHODS FOR GENETIC AND BIOLOGICAL ANALYSIS | GENAPSYS, INC. (US) | 2012-12-06 | — | — | WO | claimed |
| EP-1877757-A2 | METHOD FOR USING AN ALL SOLID-STATE FLUOROMETER IN MONITORING AND CONTROLLING CHEMICALS IN WATER | Nalco Company (US) | 2008-01-16 | — | — | EP | claimed |
| WO-2006118876-A2 | METHOD FOR USING AN ALL SOLID-STATE FLUOROMETER IN MONITORING AND CONTROLLING CHEMICALS IN WATER | NALCO COMPANY (US) | 2006-11-09 | — | — | WO | claimed |
| US-20060246595-A1 | Method for using an all solid-state fluorometer in monitoring and controlling chemicals in water | ECOLAB USA INC. | 2006-11-02 | — | — | US | claimed |
| EP-4705328-A2 | METHODS AND PLATFORM RELATED TO FLUORESCENT PROTEIN BIOSENSORS | Board of Regents, The University of Texas System (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20250290081-A1 | MICROORGANISMS FOR DITERPENE PRODUCTION | CARGILL, INCORPORATED | 2025-09-18 | — | — | US | disclosed |
| US-20250275914-A1 | PREPARATION METHOD AND CONTAINER FOR A TOPICAL WOUND HEALING GEL | REGENLAB USA LLC (US) | 2025-09-04 | — | — | US | disclosed |
| EP-0258290-A1 | METHOD AND ADDITIVES FOR IMPROVING THE QUALITY AND SHELF LIFE OF STORED BLOOD | VORA, Shobhana (US) | 1988-03-09 | — | — | EP | disclosed |
| WO-1987004072-A1 | METHOD AND ADDITIVES FOR IMPROVING THE QUALITY AND SHELF LIFE OF STORED BLOOD | VORA SHOBHANA (US) | 1987-07-16 | — | — | WO | disclosed |
| US-4451566-A | ENZYMATIC FERMENTATION OF SUGARS | SPENCER DONALD B | 1984-05-29 | — | — | US | disclosed |
| US-3929580-A | Creatine phosphokinase test indicator | "IL HOLDING S.P.A." | 1975-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250275914-A1 | PREPARATION METHOD AND CONTAINER FOR A TOPICAL WOUND HEALING GEL | BMX, PDGFA, PLAT | ENPP1 534/4885ENPP3 748/4885P2RY2 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.